Skip to Content

Cancer Research & Clinical Trials

The cancer team at Adventist HealthCare recognizes the important role that clinical trials play in the study of new, innovative treatments or strategies that may lead to prevention, earlier detection, better treatments or cures for conditions such as cancer. Our expert cancer research team includes physicians and clinical research nurses as well as research associates and assistants who are involved with more than 65 cancer studies each year.

Search or Browse Cancer Clinical Trials

Showing 1-5 of 5

Sorted By:


    Randomised, open label, multi-centre study assessing the efficacy and safety of MEDI4736 versus Standard of Care in NSCLC patients with PD-L1 positive tumours.

  • IMpower 131

    Randomized, open-label study to evaluate the safety and efficacy of Atezolizumab (MPDL3280A) in combination with carboplatin + paclitaxel or carboplatin + nab-paclitaxel.

  • IMpower 150

    Randomized, open-label study will evaluate the safety and efficacy of Atezolizumab (MPDL3280A) in combination with carboplatin and paclitaxel.


    A Phase I study to assess the systemic exposure, effiacy, and safety of 450 mg ceritinib taken with a low-fat meal and 600 mg ceritinib taken with a low-fat meal.


    Global study to assess the effects of MEDI4736 following concurrent chemoradiation in patients with Stage III unresectable non-small cell lung cancer.

Showing trials 1-5 of 5

Clincal Trials & Research Studies

Patient Stories

We’re writing new chapters in the lives of our patients, their families and our community daily. These are their stories:

Local Health News - In Your Inbox

Join over 40k of your friends & neighbors and get the latest news about community health programs and events when you sign-up for Adventist HealthCare & You Digital.

Subscribe Today!